Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline plc : Director/PDMR Shareholding

05/03/2012 | 02:11pm US/Eastern

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
React to this article
Latest news on GLAXOSMITHKLINE PLC
09/02 ADAPTIMMUNE THERAPEUTICS : Expands Trial of T-cell Therapy for Synovial Sarcoma ..
08/31 VALNEVA Reports Strong H1 2015 Revenues
08/28 GLAXOSMITHKLINE : JPML to Hear Zofran Lawsuit Consolidation Oral Arguments in Ne..
08/26 GLAXOSMITHKLINE : GSK announces NEJM publication of Phase 3b/4 study of ambrisen..
08/24 NOVARTIS : Pharma to Acquire Rights to Ofatumumab for Auto-Immune Indications fr..
08/24 AstraZeneca names Genentech's Bohen as chief medical officer
08/21 NOVARTIS : could pay more than $1B for GlaxoSmithKline MS drug
08/21DJNOVARTIS : Correction to Glaxo Sells Rights to Auto-Immune Drug to Novartis
08/21DJGlaxo Sells Rights to Auto-Immune Drug to Novartis -- Update
08/21DJPfizer Late-Stage Meningitis B Drug Studies Meet Endpoints
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials